An interventional study of Dietary intervention-whole grains and legumes and Dietary intervention-Refined rice in Impaired Fasting Glucose and Newly Diagnosed Type 2 Diabetes, sponsored by Yonsei University. Completed at 1 site in South Korea. Open to participants aged 39 Years to 74 Years. Per ClinicalTrials.gov, last updated 2013-07-10.
Sponsored by Yonsei University · Not applicable, Interventional, and Basic science
We determined the effects of dietary intervention (replacement of refined rice with whole grains and legumes and a high intake of vegetables) on circulating Lp-PLA2 activity and enzyme activity in peripheral blood mononuclear cells (PBMCs) in patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or newly-diagnosed type 2 diabetes.
Ninety-nine patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or newly-diagnosed type 2 diabetes were randomly assigned to either a control group (usual diet with refined rice) or the whole grain group.
Yonsei University is the lead sponsor of 1,410 studies on the registry; 235 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Dietary Supplement: Dietary intervention-whole grains and legumes
Dietary Supplement: Dietary intervention-Refined rice
Subjects in the whole-grain group consumed replacing of refined rice intake with 1/3 of legumes, 1/3 of barley, and 1/3 of wild rice three times per day as a carbohydrate source and increased vegetable intake to at least 6 units (30-70 g/unit) per day for sufficient dietary fiber intake.
Subjects in the control group maintained their usual diet of refined rice
Plasma Lp-PLA2 activity
Time frame: Change from baseline in Lp-PLA2 at 12 weeks
PBMC Lp-PLA2 activity
Time frame: Change from baseline in PBMC Lp-PLA2 at 12 weeks
LDL particle size
Time frame: Change from baseline in LDL particle size at 12 weeks
This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.